Kodak Triples on Loan to Make Covid-19 Drug Ingredients




 

(Bloomberg) -- Eastman Kodak Co. shares more than tripled Tuesday on a $765 million government loan to help produce ingredients used in key generic medicines to fight the coronavirus.

The development bank loan is the first of its kind under the Defense Production Act in collaboration with the U.S. Department of Defense. It's intended to speed production of drugs in short supply and those considered critical to treat Covid-19, including hydroxychloroquine, the controversial antimalarial drug touted by President Donald Trump.

The money could provide a lifeline to Kodak, the storied photography giant whose business and shares were devastated by the switch to filmless cameras. Once a stalwart of American industry with a market capitalization above $30 billion, the company declared bankruptcy in 2012, forcing it into a series of attempted reinventions including forays into printers, film for movies and, briefly, cryptocurrencies.

Now, the 132-year-old company will be reorienting part of its factory structure to produce drug ingredients, including at sites in Rochester, New York, and St. Paul, Minnesota, under a new Kodak Pharmaceuticals arm. Founded in upstate New York, the financing could be a boon for its home base that has more recently become a part of the "rust belt" after decades of key blue chip companies moving their operations and jobs overseas.

Trump, speaking Tuesday afternoon in a news conference at the White House, said the deal was "a breakthrough in bringing pharmaceutical production back to the United States" that will create 360 new jobs at the Rochester location. About 10% of the national generic drug supply is manufactured in the U.S.

The shares rose another 50% in extended trading after Trump's remarks. The stock had closed the regular trading session with a gain of 203%, bringing it to its highest price in two and a half years.

"Americans are dangerously dependent on foreign supply chains for their essential medicines," White House adviser Peter Navarro said in a statement earlier.

Kodak is now expected to produce several drug ingredients, including those used in hydroxychloroquine. The antimalarial medicine has been touted by President Trump as a treatment for the virus responsible for the pandemic, although scientists like the national virus expert Anthony Fauci have said it is not effective against Covid-19.

The stock had fallen 44% this year before Tuesday's trading and had a market value of about $115 million. Kodak ended the first quarter with a cash balance of $209 million.

(Adds Trump jobs estimate in fifth paragraph.)

For more articles like this, please visit us at bloomberg.com

Subscribe now to stay ahead with the most trusted business news source.

©2020 Bloomberg L.P.

COMMENTS

More Related News

How the next WTO chief will be chosen and the task ahead
How the next WTO chief will be chosen and the task ahead

Eight candidates from Mexico to Moldova are bidding to become the next director-general of the World Trade Organization to replace Roberto Azevedo, who steps down at the end of August. The next chief would broker international trade talks in the face of widening U.S.-China conflict, protectionism increased by the COVID-19 pandemic and pressure to reform trade rules. U.S. President Donald Trump's "America First" policies have upended the global trading order and presented an existential threat to the WTO.

One year later, El Paso reflects on the hate behind Walmart shooting
One year later, El Paso reflects on the hate behind Walmart shooting

An alleged racist attack killed 23 at an El Paso Walmart on Aug. 3, 2019. Dozens more were injured. Survivors, others reflect on hate-inspired attack.

Asian shares mixed on US-China tensions, Wall Street gains
Asian shares mixed on US-China tensions, Wall Street gains

Asian shares were mixed on Monday as investors eyeballed surging coronavirus cases in the region. U.S. Secretary of State Mike Pompeo's weekend comments that President Donald Trump plans to take action on a what he sees as a broad array of national security risks presented by software connected to the Chinese Communist Party added to market jitters. Pompeo's remarks followed reports that Microsoft is in advanced talks to buy the U.S. operations of TikTok, which is owned by the Chinese company ByteDance and is seen as a source of national security and censorship concerns by the Trump administration.

Microsoft to continue talks to buy TikTok from ByteDance
Microsoft to continue talks to buy TikTok from ByteDance

The company made the statement following a conversation between is CEO Satya Nadella and U.S. President Donald Trump. It said it would ensure that all private data of TikTok's American users is transferred to and remains in the United States.

Who could be Joe Biden
Who could be Joe Biden's running mate?

There are a lot of talented female politicians in the running - and they each have a special power.

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

  • periodic table
    (2020-07-29 01:42:27Z)

    The disease is scary, let's get through it together!

    REPLY
    • Event management assignment writing services are essential and they have become very popular for those seeking event management essay writing help services since most of them seek Event Management Writing Services.

      REPLY

Top News: Economy